Effects of indomethacin on prostanoid synthesis and vasomotor responsiveness in endothelium-denuded abdominal and thoracic aortas of Wistar rats

References

• Félétou M, Huang Y, Vanhoutte PM. Vasoconstrictor prostanoids. Pflugers Arch 2010;459(6):941–50.
   PubMed Web of Science ®Google Scholar
• Félétou M, Huang Y, Vanhoutte PM. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 2011;164:894–912.
   PubMed Web of Science ®Google Scholar
• Vanhoutte PM, Tang EHC. Endothelium-dependent contractions: when a good guy turns bad! J Physiol 2008;586(22):5295–304.
   Google Scholar
• Vanhoutte PM. Endothelium-dependent contractions in hypertension when prostacyclin becomes ugly. Hypertension 2011;57(3):526–31.
   PubMed Web of Science ®Google Scholar
• Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004;56:387–437.
   PubMed Web of Science ®Google Scholar
• Tang EH, Vanhoutte PM. Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol Genom 2008;32(3):409–18.
   PubMed Web of Science ®Google Scholar
• DeWitt DL, Day JS, Sonnenburg WK, Smith WL. Concentrations of prostaglandin endoperoxide synthase and prostaglandin I2 synthase in the endothelium and smooth muscle of bovine aorta. J Clin Invest 1983;72(6):1882–8.
   PubMed Web of Science ®Google Scholar
• Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89(16):7384–8.
   PubMed Web of Science ®Google Scholar
• Connolly C, McCormick PA, Docherty JR. Effects of the selective cyclooxygenase-2 inhibitor nimesulide on vascular contractions in endothelium-denuded rat aorta. Eur J Pharmacol 1998;352(1):53–8.
   PubMed Web of Science ®Google Scholar
• Dyer SM, Taylor DA, Bexis S, et al. Identification of a non-endothelial cell thromboxane-like constrictor response and its interaction with the renin-angiotensin system in the aorta of spontaneously hypertensive rats. J Vasc Res 1994;31(1):52–60.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Mitra S, Varadharaj S, et al. Increased expression of cyclooxygenase-2 mediates enhanced contraction to endothelin ETA receptor stimulation in endothelial nitric oxide synthase knockout mice. Circ Res 2006;98:1439–45.
   PubMed Web of Science ®Google Scholar
• Lamb VL, Schwartz AJ, Rohn WR, Kaiser L. Cyclooxygenase inhibitors depress norepinephrine constriction of rat abdominal, but not thoracic, aorta. Eur J Pharmacol 1994;256:221–6.
   PubMed Web of Science ®Google Scholar
• Asbún-Bojalil J, Castillo EF, Escalante BA, Castillo C. Does segmental difference in a1-adrenoceptor subtype explain contractile difference in rat abdominal and thoracic aortae? Vascul Pharmacol 2002;38:169–75.
   PubMed Web of Science ®Google Scholar
• Asbún-Bojalil J, Escalante B, Ceballos G, et al. Segmental differences in rat aorta contraction induced by phenylephrine in aortic rings. Proc West Pharmacol Soc 1999;42:23–4.
   PubMedGoogle Scholar
• Nebigil C, Malik KU. α-Adrenergic receptor subtypes involved in prostaglandin synthesis are coupled to Ca++ channels through a pertussis toxin-sensitive guanine nucleotide-binding protein. J Pharmacol Exp Ther 1993;266:1113–24.
   PubMed Web of Science ®Google Scholar
• Nebigil C, Malik KU. Comparison of signal transduction mechanisms of alpha-2C and alpha-1A adrenergic receptor-stimulated prostaglandin synthesis. J Pharmacol Exp Ther 1992;263:987–96.
   PubMed Web of Science ®Google Scholar
• Nebigil C, Malik KU. Prostaglandin synthesis elicited by adrenergic stimuli is mediated via alpha-2C and alpha-1A adrenergic receptors in cultured smooth muscle cells of rabbit aorta. J Pharmacol Exp Ther 1992;260:849–58.
   PubMed Web of Science ®Google Scholar
• Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232–5.
   PubMedGoogle Scholar
• Lucas S. The pharmacology of indomethacin. Headache 2016;56(2):436–46.
   PubMed Web of Science ®Google Scholar
• Guo DC, Papke CL, He R, Milewicz DM. Pathogenesis of thoracic and abdominal aortic aneurysms. Ann N Y Acad Sci 2006;1085:339–52.
   PubMed Web of Science ®Google Scholar
• Ghorpade A, Baxter BT. Biochemistry and molecular regulation of matrix macromolecules in abdominal aortic aneurysms. Ann NY Acad Sci 1996;800:138–50.
   PubMed Web of Science ®Google Scholar
• Sokolis DP, Boudoulas H, Karayannacos PE. Segmental differences of aortic function and composition: clinical implications. Hellenic J Cardiol 2008;49:145–54.
   PubMed Web of Science ®Google Scholar
• Assoul N, Flaud P, Chaouat M, et al. Mechanical properties of rat thoracic and abdominal aortas. J Biomech 2008;41(10):2227–36.
   PubMed Web of Science ®Google Scholar
• Padilla J, López RM, López P, et al. Inhibition of PKC-dependent extracellular Ca2+ entry contributes to the depression of contractile activity in long-term pressure-overloaded endothelium-denuded rat aortas. Braz J Med Biol Res 2014;47(9):789–98.
   PubMed Web of Science ®Google Scholar
• Gluais P, Lonchampt M, Morrow JD, et al. Acetylcholine-induced endothelium-dependent contractions in the SHR aorta, the Janus face of prostacyclin. Br J Pharmacol 2005;146(6):834–45.
   PubMed Web of Science ®Google Scholar
• Patrignani P, Patrono C. Cyclooxygenase inhibitors: from pharmacology to clinical read-outs. Biochim Biophys Acta 2015;1851(4):422–32.
   PubMed Web of Science ®Google Scholar
• Liu B, Luo W, Zhang Y, et al. Involvement of cyclo-oxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries. Exp Physiol 2012;97(2):277–89.
   PubMed Web of Science ®Google Scholar
• Simplicio JA, Resstel LB, Tirapelli DP, et al. Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatment. Vascul Pharmacol 2015;73:124–37.
   PubMed Web of Science ®Google Scholar
• Riendeau D, Percival MD, Boyce S, et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 1997;121(1):105–17.
   PubMed Web of Science ®Google Scholar
• FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001;345:433–42.
   PubMed Web of Science ®Google Scholar
• Gluais P, Paysant J, Badier-Commander C, et al. In SHR aorta, calcium ionophore A-23187 releases prostacyclin and thromboxane A2 as endothelium-derived contracting factors. Am J Physiol Heart Circ Physiol 2006;291(5):H2255–64.
   PubMed Web of Science ®Google Scholar
• Gluais P, Vanhoutte PM, Félétou M. Mechanisms underlying ATP-induced endothelium-dependent contractions in the SHR aorta. Eur J Pharmacol 2007;556(1–3):107–14.
   PubMed Web of Science ®Google Scholar
• Bauer J, Ripperger A, Frantz S, et al. Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation. Br J Pharmacol 2014;171(13):3115–31.
   PubMed Web of Science ®Google Scholar
• Tang EH, Leung FP, Huang Y, et al. Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor. Br J Pharmacol 2007;151:1523.
   Web of Science ®Google Scholar
• Smyth EM, Grosser T, Wang M, et al. Prostanoids in health and disease. J Lipid Res 2009;50:S423–8.
   PubMed Web of Science ®Google Scholar
• Weksler BB. Prostanoids and NSAIDs in cardiovascular biology and disease. Curr Atheroscler Rep 2015;17(7):41.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Hancock JF, Lichtenberger LM. The nonsteroidal anti-inflammatory drug indomethacin induces heterogeneity in lipid membranes: potential implication for its diverse biological action. PLoS One 2010;5(1):e8811.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Plowman SJ, Lichtenberger LM, Hancock JF. The anti-inflammatory drug indomethacin alters nanoclustering in synthetic and cell plasma membranes. J Biol Chem 2010;285(45):35188–95.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Cho KJ, Plowman SJ, Hancock JF. Nonsteroidal anti-inflammatory drugs alter the spatiotemporal organization of Ras proteins on the plasma membrane. J Biol Chem 2012;287(20):16586–95.
   PubMed Web of Science ®Google Scholar
• Pereira-Leite C, Nunes C, Reis L. Interaction of nonsteroidal anti-inflammatory drugs with membranes: in vitro assessment and relevance for their biological actions. Prog Lipid Res 2013;52(4):571–84.
   PubMed Web of Science ®Google Scholar
• Taddei S, Virdis A, Ghiadoni L, et al. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 1997;29:274–9.
   PubMed Web of Science ®Google Scholar
• Lüscher TF, Cooke JP, Houston DS, et al. Endothelium-dependent relaxations in human arteries. Mayo Clin Proc 1987;62:601–6.
   PubMed Web of Science ®Google Scholar
• Taddei S, Virdis A, Mattei P, et al. Hypertension causes premature aging of endothelial function in humans. Hypertension 1997;29:736–43.
   PubMed Web of Science ®Google Scholar
• Emori HW, Champion GD, Bluestone R, Paulus HE. Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid. Ann Rheum Dis 1976;32:433–5.
   Web of Science ®Google Scholar